BDBM498051 US11008314, Compound 134

SMILES COc1cc(C)c(Sc2cnc(Nc3ccc(CN(C)C)cn3)s2)cc1C(=O)N1CCN(CC1)C(=O)C=C

InChI Key InChIKey=YEYNIMGLTASSDW-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 498051   

TargetTyrosine-protein kinase BTK(Human)
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498051(US11008314, Compound 134)
Affinity DataIC50: 10nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498051(US11008314, Compound 134)
Affinity DataIC50: 10nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2021
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498051(US11008314, Compound 134)
Affinity DataIC50: 10nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2021
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Corvus Pharmaceuticals

US Patent
LigandPNGBDBM498051(US11008314, Compound 134)
Affinity DataIC50: 55nMAssay Description:The potency of inhibition is measured by binding affinity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/15/2021
Entry Details
US Patent